Seeing Is Believing
Currently, out of the existing stock ratings of Gena Wang - 175 which are a Buy (62.72%), 76 which are a Hold (27.24%), 28 which are a Sell (10.04%)
Analyst Gena Wang works at BARCLAYS and is covering Healthcare, Energy sectors with 541 price targets and ratings displayed on 41 stocks. Previously, Gena Wang worked at JEFFERIES.
Gena Wang's average stock forecast success ratio is 61.77% with an average time for price targets to be met of 167.15 days.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 18-Sep-2023.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 12/29/2020. The price target of $46 was fulfilled within 1 day with a profit of $3.64 (8.59%) receiving and performance score of 85.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
405
$229.48 (130.74%)
405
3 days ago
1/11 (9.09%)
$187.04 (111.43%)
664
Buy
240
$64.48 (36.74%)
247
7 days ago
18/21 (85.71%)
$25.52 (27.24%)
430
Buy
240
$64.48 (36.74%)
240
7 days ago
7/11 (63.64%)
$25.57 (14.48%)
233
Buy
270
$94.48 (53.83%)
270
9 days ago
3/10 (30%)
$52.1 (27.25%)
119
Buy
250
$74.48 (42.43%)
250
1 months 13 days ago
9/12 (75%)
$45.83 (47.46%)
396
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?